Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2025
2024
2023
2022
2021
2020
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2024
Home
2024
March 3, 2025
Published by
Dominic Burg
on
March 3, 2025
Categories
Completion of Face Medi Group Sale
March 3, 2025
Published by
Dominic Burg
on
March 3, 2025
Categories
Release of Shares from Voluntary Escrow
March 3, 2025
Published by
Dominic Burg
on
March 3, 2025
Categories
Restructuring Update
March 3, 2025
Published by
Dominic Burg
on
March 3, 2025
Categories
Appendix 4G and Corporate Governance Statement 2024
March 3, 2025
Published by
Dominic Burg
on
March 3, 2025
Categories
Market Update
March 3, 2025
Published by
Dominic Burg
on
March 3, 2025
Categories
Annual Report to shareholders
March 3, 2025
Published by
Dominic Burg
on
March 3, 2025
Categories
VOLUNTARY SUSPENSION UPDATE
September 4, 2024
Published by
Dominic Burg
on
September 4, 2024
Categories
Suspension from Official Quotation
September 3, 2024
Published by
Dominic Burg
on
September 3, 2024
Categories
Trading Halt
Prev page
1
2
3
4
5
6
Next page
